Schedule 13G ownership disclosure

RAPT THERAPEUTICS INC

Common Stock · CUSIP: 75382E109

Event date: 2025-03-31

Filing-level shares
8,278,798
Percent of class
6.27%
  • The Vanguard Group

    Shares: 8,278,798 · Class: 6.27%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000932471-25-000552
Form type
SCHEDULE 13G
Filer
RAPT Therapeutics, Inc.
CIK
CIK 1673772
Filed
Apr 30, 2025
Reporting period
Mar 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub